Table 2.
Study characteristics9–42
| Study | Imaging modality | Stage of imaging | nG2 | nG3 | nG4 |
|---|---|---|---|---|---|
| Hakyemez et al35 | DSC | Preoperative | 8 | 18 | |
| Wolf et al42 | CASL | Preoperative | 5 | 8 | 11 |
| Bastin et al31 | DSC | Preoperative | 10 | ||
| Kim et al37 | PASL | Preoperative | 11 | 7 | 15 |
| Haris et al36 | DCE | Preoperative | 17 | 7 | 35 |
| Kim et al38 | PASL | Preoperative | 26 | ||
| Weber et al41 | PASL, DSC | Preoperative | 12 | 26 | 24 |
| Server et al39 | DSC | Preoperative | 18 | 14 | 47 |
| Thomsen et al40 | DSC | Preoperative, post-treatment | 6 | 38 | |
| Fellah et al33 | DSC | Preoperative | 24 | 26 | |
| Artzi et al30 | DSC | Post-treatment | 14 | ||
| Falk et al32 | DSC, DCE | Preoperative | 18 | 7 | |
| Furtner et al34 | PASL | Preoperative | 14 | ||
| Andre et al10 | pCASL | Recurrence | 18 | ||
| Qiao et al24 | pCASL | Preoperative | 53 | ||
| Smitha et al25 | DSC | Preoperative | 15 | 18 | 7 |
| Lin et al19 | pCASL | Preoperative | 24 | ||
| Petr et al22 | pCASL | Post-treatment | 24 | ||
| Puig et al23 | DSC | Preoperative | 15 | ||
| Yang et al27 | PASL | Preoperative | 15 | 15 | 13 |
| Ganbold et al13 | pCASL | Preoperative | 25 | ||
| Kim et al16 | pCASL | Recurrence | 72 | ||
| Lin et al20 | DSC | Preoperative | 18 | 15 | |
| Zeng et al29 | pCASL | Preoperative | 13 | 17 | 28 |
| Brendle et al11 | DCE, PASL | Preoperative | 20 | ||
| Durmo et al12 | DSC | Preoperative | 10 | ||
| Han et al14 | pCASL | Preoperative | 92 | ||
| Khashbat et al15 | pCASL | Preoperative | 6 | ||
| Komatsu et al17 | ASL - type unspecified | Preoperative | 40 | 18 | 44 |
| Lee et al18 | DSC | Preoperative | 89 | ||
| Liu et al21 | pCASL | Preoperative | 22 | ||
| Stadlbauer et al26 | DSC | Preoperative, post-treatment | 57 | ||
| You et al28 | pCASL | Preoperative | 93 | ||
| Sengupta et al43 | DCE | Preoperative | 15 | 12 | 26 |
CASL, Continuous arterial spin labelling; DCE, Dynamic contrast enhanced MRI; DSC, Dynamic susceptibility contrast MRI; G2, WHO grade two gliomas; G3, WHO grade three gliomas; G4, WHO grade four gliomas; PASL, Pulsed arterial spin labelling; pCASL, Pseudo continuous-continuous arterial spin labelling.
34 studies were included in the final quantitative meta-analysis. Please note that the numbers refer to the number of patients in the study. Most studies reported imaging metrics at the preoperative stage. G4 tumours were the most commonly studied.